Results

Total Results: 898 records

Showing results for "type".

321. Evidence Summary: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/falls-prevention-community-dwelling-older-adults-interventions
     June 04, 2024 - Publication type: Publication was not an included publication type.

322. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Njxn2r3qtWKdBf2_VhS2Aw
     April 01, 2016 - Data were too limited to generate consistent or de- finitive results for any specific type of cancer … Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a

323. Task Force Issues Final Recommendation Statement on Screening for Latent Tuberculosis Infection (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/latent-tb-screening-final-rec-bulletin.pdf
     May 02, 2023 - Task Force Issues Final Recommendation Statement on Screening for Latent Tuberculosis Infection www.uspreventiveservicestaskforce.org 1 Task Force Issues Final Recommendation Statement on Screening for Latent Tuberculosis Infection Adults at increased risk for tuberculosis should be screened WASHINGTON,…

324. U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening Children for Lipid Disorders (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/lipid-disorders-screening-children-adolescents-final-rec-bulletin.pdf
     July 18, 2023 - U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening Children for Lipid Disorders 1 www.uspreventiveservicestaskforce.org U.S. Preventive Services Task Force Issues Final Recommendation Statement on Screening Children for Lipid Disorders Task Force determines that more …

325. Task Force Issues Draft Recommendation Statement on Screening for Latent Tuberculosis Infection (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/latent-tbi-screening-adults-draft-rec-bulletin.pdf
     December 27, 2022 - Task Force Issues Draft Recommendation Statement on Screening for Latent Tuberculosis Infection www.uspreventiveservicestaskforce.org 1 Grade in this recommendation: B: Recommended. Learn more here Task Force Issues Draft Recommendation Statement on Screening for Latent Tuberculosis Infection Peo…

326. Procedure Manual Section 3. Topic Work Plan Development | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-section-3-topic-work-plan-development
     June 22, 2025 - The population appears at the left margin of the diagram and specifies the type(s) of patients to whom

327. Primary Care Interventions to Promote Breastfeeding: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8KtbKJonvmWq8q6q-bGskR
     January 01, 2010 - Children who were not breastfed were more likely to have asthma, type 2 diabetes, and obesity (6). … er respiratory tract, or gastrointestinal infections Young children: Less likelihood of asthm a, type

328. Screening and Treatment for Hypercholesterolemia in Children and Adolescents: Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/CW23r2jqogvTG2_-kBjRxH
     January 01, 2007 - Neonatal diagnosis of familial type-II hyperlipoproteinaemia. … Colestipol in familial type II hyperlipoproteinemia: a three-year trial. … Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin. … Colestipol in familial type II hyperlipoproteinemia: a three-year trial. … Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.

329. Archived: Final Research Plan: Child Maltreatment: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/child-maltreatment-primary-care-interventions-november-2018
     August 18, 2016 - None Languages Full text published in English Languages other than English Publication type

330. JAMA JATS (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/pKa4_DYwzuyD6RDgYzLMbo
     August 22, 2018 - Search Flow Diagram: Screening for Intimate Partner Violence 348 Articles excluded 88 Publication type … Articles (30 studies) included in systematic review for KQs 1-5 Reasons for exclusion: Publication type … Measure No. of SessionsSource IPV (any type) 643 12WeeklyHome visiting CTS-2Bair-Merritt et al,33 … 2010 –0.04 (–0,23 to 0.14) IPV (specific type)a 110 51Counseling (IPV) CTS-2 (minor physical)Tiwari … ) Hegarty et al,39 2013 Miller et al,41 2016 Rhodes et al,42 2015 IPV (specific type)a Miller et al

331. Archived: Final Research Plan: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/osteoporosis-screening-june-2018
     November 05, 2015 - fair quality Poor quality Language English Languages other than English Publication type

332. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
     November 13, 2016 - Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type … Two-year statin therapy does not alter the progression of intima-media thickness in patients with type … Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative … The statins in prevention of coronary heart diseases in type 2 diabetics. … Statin therapy and risk of developing type 2 diabetes: a meta-analysis.

333. 6Jfgjyjsbmc48Mj2Uksahb (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6jFgJYJSbMc48mj2uKsAhB
     October 01, 2014 - recommends programs promot- ing diet and physical activity for persons who are at in- creased risk for type … weight reduction through a healthful diet and physical activity could prevent or delay the onset of type … Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

334. Archived: Final Research Plan: Syphilis Infection in Pregnant Women: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/syphilis-infection-in-pregnancy-screening-september-2018
     August 31, 2017 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Syphilis Infection in Pregnant Women: Screening August 31, 2017 Recommendations made by the USPSTF are independent of the U.S. government. The…

335. More Information on the Final Recommendation: Autism Spectrum Disorder in Young Children: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/more-information-on-the-final-recommendation/autism-spectrum-disorder-in-young-children-screening
     February 16, 2016 - Share to Facebook Share to X Share to WhatsApp Share to Email Print More Information on the Final Recommendation Autism Spectrum Disorder in Young Children: Screening February 16, 2016 Recommendations made by the USPSTF are independent of the …

336. Final Recommendation Statement: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/cervical-cancer-screening
     August 21, 2018 - the higher than average rate of adenocarcinoma, which carries a worse prognosis than the most common type … Decreases in hrHPV type prevalence due to vaccination could reduce the positive predictive value of hrHPV … Meta-analysis was not possible because the trials varied substantially in terms of cytology type (conventional … when the infection is not cleared by an appropriate immune response and the virus is of an oncogenic type

337. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/MzHhsgTBL37rRvvJfkfgMZ
     August 20, 2019 - associations.56,58,63,68,71,72,80,81 Some studies showed mixed re- sults that varied by subgroup or type … evaluated in 4 additional studies in United Kingdom and Canada (2880) First-, second-, and third-degree Type … pathology (histology and hormone receptor status) of index patient in addition to original factors: type … ages based on a large external data set; BRCAPRO-LYTE-simple imputes the number of relatives for each type … improve a woman’s under- standing of her risk of developing BRCA1/2-related cancer depending on the type

338. How to Read the New Recommendation Statement: Methods Update (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/methupd.pdf
     July 01, 2007 - provides a more detailed description of con- siderations specific to the particular recommendation or type

339. Evidence Summary: Oral Health in Children and Adolescents Aged 5 to 17 Years: Screening and Preventive Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/oral-health-children-adolescents-screening-preventive-interventions
     November 07, 2023 - There were no statistically significant interactions between control type, follow-up duration, or age … There was marked statistical heterogeneity ( I 2 = 91%), with estimates that varied by control type … concentration, follow-up duration, application frequency, time since permanent teeth eruption, or control type … no benefit of xylitol (vs no xylitol 15 ) or reported results that varied depending on the control type … fair-quality trials) Only 2 fair-quality trials; potential differences in outcomes based on control type

340. Archived: Speech and Language Delay and Disorders in Children Age 5 and Younger: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening-july-2015
     July 07, 2015 - natural history of these disorders is limited, because most affected children receive at least some type … previous evidence review 6 found that 55% of parents reported that their toddler did not receive any type … intervention effectiveness, including the potential effects of age at diagnosis, age at treatment, treatment type